Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections

[1]  S. Singhal,et al.  Sodium Multivitamin Transporter-Targeted Fluorochrome Facilitates Enhanced Metabolic Evaluation of Tumors Through Coenzyme-R Dependent Intracellular Signaling Pathways , 2022, Molecular Imaging and Biology.

[2]  Jian Liu,et al.  Expert consensus on indocyanine green fluorescence imaging for thoracoscopic lung resection (The Version 2022) , 2022, Translational lung cancer research.

[3]  S. Singhal,et al.  Precision Surgery Guided by Intraoperative Molecular Imaging , 2022, The Journal of Nuclear Medicine.

[4]  S. Singhal,et al.  Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  S. Singhal,et al.  Effects of Light-absorbing Carbons in Intraoperative Molecular Imaging–Guided Lung Cancer Resections , 2022, Molecular Imaging and Biology.

[6]  S. Singhal,et al.  Targeted Intraoperative Molecular Imaging for Localizing Nonpalpable Tumors and Quantifying Resection Margin Distances. , 2021, JAMA surgery.

[7]  John Y. K. Lee,et al.  Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections , 2021, Molecular Imaging and Biology.

[8]  Min Wu,et al.  Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex , 2020, Signal Transduction and Targeted Therapy.

[9]  P. Low,et al.  A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer. , 2019, Gynecologic oncology.

[10]  Andrew D. Newton,et al.  A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas. , 2018, The Annals of thoracic surgery.

[11]  Eric Faulkner,et al.  PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics , 2018, Diagnostic Pathology.

[12]  Sunil Singhal,et al.  Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  P. Low,et al.  Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging , 2015, International journal of molecular imaging.

[14]  G. Giaccone,et al.  Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States , 2015, Front. Oncol..

[15]  Jinzuo Ye,et al.  Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology , 2014, Theranostics.

[16]  S. Singhal,et al.  Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. , 2013, Surgical oncology.

[17]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[18]  S. Singhal,et al.  Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance , 2012, Oncotarget.

[19]  Philip S Low,et al.  Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. , 2004, Advanced drug delivery reviews.